
Opinion|Videos|May 22, 2024
Key Takeaways Following MAJIC-PV
Gabriela Hobbs, MD, and Timothy Mok, PharmD, BCPS, BCOP, close the discussion with key takeaways for payers to consider related to ruxolitinib and insights on future research.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement














